Non-Hodgkin Lymphoma Clinical Trials in Wuhan, Hubei
8 recruitingWuhan, Hubei, China
Showing 1–8 of 8 trials
Recruiting
Phase 1Phase 2
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+6 more
BeOne Medicines614 enrolled127 locationsNCT05006716
Recruiting
Phase 1Phase 2
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
Non-Hodgkin LymphomaMantle Cell LymphomaFollicular Lymphoma+6 more
BeiGene146 enrolled29 locationsNCT05294731
Recruiting
Phase 1
KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Non-Hodgkin Lymphoma
TCRx Therapeutics Co.Ltd18 enrolled1 locationNCT07260812
Recruiting
Phase 1
PIC1 Injection Therapy for Relapsed/Refractory B-NHL
Non-Hodgkin Lymphoma
Chongqing Precision Biotech Co., Ltd18 enrolled1 locationNCT07456371
Recruiting
Phase 1
The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma
Non-hodgkin Lymphoma,B Cell
Bioray Laboratories18 enrolled3 locationsNCT05741359
Recruiting
Early Phase 1
An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies
Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology40 enrolled1 locationNCT07101705
Recruiting
Phase 1
A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas
Non-Hodgkin Lymphoma
Hangzhou GluBio Pharmaceutical Co., Ltd.110 enrolled13 locationsNCT06219356
Recruiting
Early Phase 1
An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin Lymphoma (B-NHL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology13 enrolled1 locationNCT06693973